VIP and PACAP in pain and inflammation

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.21, Iss.2, 2000-02, pp. : 57-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VIP and PACAP: very important in pain?

By Dickinson T. Fleetwood-Walker S.M.

Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. : 324-329

Elsevier

Access to resources Recommend Favorite

Interaction of lipophilic VIP derivatives with recombinant VIP 1 /PACAP and VIP 2 /PACAP receptors

By Gourlet P. Rathe J. De Neef P. Cnudde J. Vandermeers-Piret M.-C. Waelbroeck M. Robberecht P.

European Journal of Pharmacology, Vol. 354, Iss. 1, 1998-07 ,pp. : 105-111

Elsevier

Access to resources Recommend Favorite

The Neuropeptides VIP / PACAP and T Cells: Inhibitors or Activators?

Current Pharmaceutical Design, Vol. 9, Iss. 12, 2003-05 ,pp. : 997-1004

Bentham Science Publishers

Access to resources Recommend Favorite

Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis

Current Pharmaceutical Design, Vol. 17, Iss. 10, 2011-04 ,pp. : 1025-1035

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide Mimetics and Antagonists in the Treatment of Inflammatory Disease: Focus on VIP and PACAP

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-01 ,pp. : 151-163

Bentham Science Publishers

Access to resources Recommend Favorite